Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q2 2026 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2026-08-04

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q2 2026 (← Previous) (Next →)

Filing Date: Aug 4, 2026

Total Value: $177M (100.0% shares, 0.0% debt)

Holdings (3)

PHAT PHATHOM PHARMACEUTICALS INC 45.6%

Value $80.99M Shares 7,464,572 Share Price $10.85 Est. Cost/Share $13.72 Unrealized @ Report Date -20.9%

NAMS NEWAMSTERDAM PHARMA COMPANY 42.2%

Value $74.85M Shares 2,208,639 Share Price $33.89 Est. Cost/Share $10.96 Unrealized @ Report Date +209.3%

AURA AURA BIOSCIENCES INC 12.2%

Value $21.58M Shares 3,039,892 Share Price $7.10 Est. Cost/Share $17.87 Unrealized @ Report Date -60.3%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	7,464,572	$80.99M	45.6%	$10.85	$13.72	-20.9%	COM	71722W107
NAMS	NEWAMSTERDAM PHARMA COMPANY	2,208,639	$74.85M	42.2%	$33.89	$10.96	+209.3%	ORDINARY SHARES	N62509109
AURA	AURA BIOSCIENCES INC	3,039,892	$21.58M	12.2%	$7.10	$17.87	-60.3%	COM	05153U107